36 Participants Needed

Mandibular Advancement Device for Nocturia

(MAD Trial)

IM
FY
Overseen ByFernanda Yanez Regonesi, DDS, MS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests if a mouthpiece that keeps the lower jaw forward can help people who frequently urinate at night by improving their sleep. These devices have been used to help with breathing issues during sleep.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are using combination therapy for obstructive sleep apnea, such as positive airway pressure therapy, you may not be eligible to participate.

Is the Mandibular Advancement Device safe for humans?

Mandibular advancement devices, like Somnodent, are generally well-tolerated and considered safe for treating conditions like snoring and sleep apnea. Some studies report good acceptance and minor side effects, but there can be dental and skeletal changes over time.12345

How does the treatment Somnodent Classic differ from other treatments for nocturia?

The Somnodent Classic is a mandibular advancement device, typically used for sleep apnea, that works by adjusting the position of the lower jaw to improve airflow during sleep. This approach is unique for nocturia (frequent nighttime urination) as it is non-invasive and primarily targets sleep-related breathing issues, which may indirectly affect nocturia symptoms.12367

What data supports the effectiveness of the treatment Somnodent Classic for nocturia?

Mandibular advancement devices, like Somnodent Classic, have been shown to improve sleep quality and reduce snoring in people with obstructive sleep apnea, which might indirectly help with nocturia (frequent nighttime urination) by improving overall sleep patterns.12367

Who Is on the Research Team?

FY

Fernanda Yanez Regonesi, DDS, MS

Principal Investigator

University Of Kentucy

Are You a Good Fit for This Trial?

This trial is for adults over 18 with obstructive sleep apnea (AHI≥5) who experience at least two trips to the bathroom per night. Participants must have ≥8 teeth per arch, be able to move their jaw forward by ≥5mm, and speak English. People can't join if they're pregnant, have certain medical conditions like heart failure or diabetes, use diuretics, or are already using other treatments for sleep apnea.

Inclusion Criteria

Consent to participate in the study.
I am older than 18 years.
I have at least 8 teeth in each jaw and can move my lower jaw forward by 5 mm or more.
See 5 more

Exclusion Criteria

I have severe gum disease, loose teeth, cavities, or am getting dental treatments.
I struggle with coordination or using my hands.
Pregnancy
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are fitted with a mandibular advancement device (MAD) and undergo titration every 2 weeks until nocturia is reduced to less than 2 voidings per night.

15 weeks
Bi-weekly visits for titration

Follow-up

Participants are monitored for safety and effectiveness after treatment, including a second sleep study to assess treatment success.

4 weeks
1 visit (in-person) for sleep study

What Are the Treatments Tested in This Trial?

Interventions

  • Somnodent Classic
Trial Overview The study is examining whether a mandibular advancement device (MAD), specifically the Somnodent Classic model, can reduce nighttime urination (nocturia) in people with obstructive sleep apnea.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: MAD therapyExperimental Treatment1 Intervention

Somnodent Classic is already approved in United States, Canada, European Union for the following indications:

🇺🇸
Approved in United States as SomnoDent Classic for:
🇨🇦
Approved in Canada as SomnoDent Classic for:
🇪🇺
Approved in European Union as SomnoDent Classic for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Fernanda Yanez Regonesi

Lead Sponsor

Trials
1
Recruited
40+

American Academy of Dental Sleep Medicine

Collaborator

Trials
1
Recruited
40+

Published Research Related to This Trial

Mandibular advancement devices have been shown to significantly improve symptoms of obstructive sleep apnea syndrome (OSAS), particularly by reducing the frequency of apneas and hypopneas, which leads to better sleep quality and less snoring as reported by bed partners.
Polysomnographic improvements were noted, with some patients achieving an apnea-hypopnea index of less than 10 per hour, although results varied, with some individuals experiencing no improvement or worsening of their condition.
[Mandibular advancement orthoses used in the treatment of obstructive sleep apnea syndrome].Petitjean, T., Garcia Tejero, MT., Langevin, B., et al.[2006]
Mandibular advancement devices have been shown to significantly improve symptoms of obstructive sleep apnea syndrome (OSAS), particularly by reducing the frequency of apneas and hypopneas, which leads to better sleep quality and less snoring as reported by bed partners.
Polysomnographic improvements were noted, with some patients achieving an apnea-hypopnea index of less than 10 per hour, although results varied, with some patients experiencing no improvement or worsening of symptoms.
[Mandibular advancement orthotic for treatment of obstructive sleep apnea].Petitjean, T., Garcia Tejero, MT., Langevin, B., et al.[2006]
The mandibular advancement device (MAD) Somnoguard significantly reduced the respiratory disturbance index (RDI) in 44 patients with obstructive sleep apnea (OSA), indicating improved breathing during sleep.
68% of patients experienced either a cure or substantial improvement in their condition, along with a notable increase in minimal oxygen saturation and a decrease in snoring time, demonstrating the device's efficacy as an alternative treatment for those noncompliant with continuous positive airway pressure.
A mandibular advancement device for the ENT office to treat obstructive sleep apnea.Maurer, JT., Huber, K., Verse, T., et al.[2013]

Citations

[Mandibular advancement orthoses used in the treatment of obstructive sleep apnea syndrome]. [2006]
[Mandibular advancement orthotic for treatment of obstructive sleep apnea]. [2006]
A mandibular advancement device for the ENT office to treat obstructive sleep apnea. [2013]
Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: A systematic review. [2022]
Pilot study of a novel mandibular advancement device for the control of snoring. [2019]
[Objective assessment and therapeutic efficacy of an improved mandibular advancement device for snoring and sleep apnea syndromes with polysomnography]. [2019]
Dental and Skeletal Side Effects of Oral Appliances Used for the Treatment of Obstructive Sleep Apnea and Snoring in Adult Patients-A Systematic Review and Meta-Analysis. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security